Eyerising International
PrivateLast Round
Accelerator
May 19, 2026
Total Funding Raised
$10,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Eyerising International operates in Healthcare & Life Sciences and is based in South Yarra. Its latest recorded funding round was an Accelerator round in May 2026.
Eyerising International is a medical technology company that develops and markets the Eyerising Myopia Management Device, a home-use medical device utilizing repeated low-level red-light (RLRL) therapy to slow the progression of myopia in children.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Patient Engagement, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eyerising International Comparables
Compare Eyerising International with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing Yishiliang Medical Technology Co., Ltd. | 88% | |
| Dopavision | 82% | |
| Beijing Mingren Shikang Science & Technology Co., Ltd. | 80% |
For institutional investors. Book with your work email.
Eyerising International Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 19, 2026 | ||||
| Series A | Feb 16, 2026 | ||||
| Grant | Nov 7, 2025 |
For institutional investors. Book with your work email.
Eyerising International Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator |
| Hong Kong Science and Technology Parks Corporation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Received funding from MedTech Innovator.
- Apr 22, 2026
Grew 43% QoQ, from 7 to 10 employees.
For institutional investors. Book with your work email.
Eyerising International Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Eyerising International's valuation, stock price, and market status.
Is Eyerising International a public or private company?
Eyerising International is a private company.
What is the current stock price of Eyerising International?
Eyerising International is a private company, so its shares have no public market price. Caplight tracks Eyerising International's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eyerising International worth (valuation)?
Valuation information for Eyerising International is not publicly available.
Can I buy Eyerising International stock?
Eyerising International shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eyerising International's last funding round?
Eyerising International's most recent funding round was Accelerator on May 19, 2026.
Who are the main investors in Eyerising International?
Key investors in Eyerising International include MedTech Innovator, Hong Kong Science and Technology Parks Corporation.
Will Eyerising International IPO soon?
No public IPO plans have been announced for Eyerising International.
How can I track Eyerising International secondary market activity?
Caplight tracks bids, offers, and trades in Eyerising International's shares on secondary markets.